Log in
Enquire now
‌

US Patent 7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor

Patent 7329640 was granted and assigned to Dendreon on February, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Dendreon
Dendreon
0
Date Filed
September 12, 2006
0
Date of Patent
February 12, 2008
0
Patent Application Number
11520079
0
Patent Citations Received
‌
US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
0
‌
US Patent 11685771 Recombinant factor VIII proteins
0
Patent Inventor Names
George P. Vlasuk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7329640
0
Patent Primary Examiner
‌
Karen Cochrane Carlson
0

Find more entities like US Patent 7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.